测试版
试验雷达 AI
临床试验 NCT06716931 (DM2) 针对Myotonic Dystrophy 2目前招募中。请查看临床试验雷达卡片视图和 AI 发现工具了解所有详情,或在此提出任何问题。
一个试验符合筛选条件
卡片视图

Investigating Exercise in Myotonic Dystrophy Type 2 (DM2)

招募中
临床试验详情主要以英语提供。然而,试验雷达 AI可以提供帮助!只需点击“解释临床试验”即可查看和讨论您选择的语言的试验信息。
临床试验NCT06716931 (DM2)是一项针对Myotonic Dystrophy 2干预性研究试验,目前试验状态为招募中。试验始于2025年3月4日,计划招募24名患者。该研究由Massachusetts General Hospital主导,预计于2026年3月1日完成。试验数据来源于ClinicalTrials.gov,最后更新时间为2025年9月29日
简要概括
An exercise regimen (PRIME: Proximal Resistance In-House Movement Exercise) has been designed for patients with myotonic dystrophy type 2 (DM2). The hypothesis is that this patient-friendly physical therapist (PT)-guided exercise program associates with improved functional capacity and muscle composition in DM2 in this two-period two-sequence cross-over study. Thus, participant will be randomized to one of the three possible groups. Participants in GROUP A will perform exercise routine in clinic under the direct supervision of a physical therapist twice a week for the first three months, then they will continue with same exercise routine at home for the last 3 months on their own. Participants in GROUP B will perform exercise routine virtually under the direct supervision of a physical therapist twice a week for the first three months, then they will continue with same exercise routine at home for the last 3 months on their own. Participants in GROUP C will perform exercise routine on their own during the first 3 months, then they will perform exercise routine virtually under the direct supervision of a physical therapist. Each group will include around 8 participants. Duration of the study is 6 months. In addition to exercise sessions, participants will have evaluation of their strength, motor function and muscle composition at three time points: initiation, 3 months and completion of the study at 6 months. Muscle composition will be assessed by electrical impedance myography which is a portable, non-invasive, painless and non-radiation tool that applies a weak high multifrequency electrical current to the examined muscle and allows to obtain information about its composition.
官方标题

Investigating Benefits of A Physical Therapist (PT)-Guided Exercise Program in Myotonic Dystrophy Type 2 (DM2)

疾病
Myotonic Dystrophy 2
其他研究标识符
  • DM2
  • PGP-ZS
NCT编号
实际开始日期
2025-03-04
最近更新发布
2025-09-29
预计完成日期
2026-03-01
计划入组人数
24
研究类型
干预性研究
试验分期 (阶段)
不适用
试验状态
招募中
关键词
exercise
physical therapist
myotonic dystrophy type 2
electrical impedance myography
主要目的
治疗方法
分配方式
随机
干预模型
交叉
盲法
无(开放性试验)
试验组/干预措施
参与者组/试验组干预措施/治疗方法
阳性对照Group A
Exercise under the supervision of physical therapist in clinic during the first 3 months, then self-directed exercise routine for the last 3 months
锻炼
A patient-friendly exercise routine has been designed for patients with myotonic dystrophy type 2. Benefits of this exercise regimen in different settings (at home versus clinic, self-directed versus physical therapist-directed) will be investigated. In person exercise supervised by physical therapist and then self-directed exercise in Group A
阳性对照Group B
Exercise under the supervision of physical therapist virtually during the first 3 months, then self-directed exercise routine for the last 3 months
锻炼
Exercise virtually supervised by physical therapist and then self-directed for group B
阳性对照Group C
Self-directed exercise routine for the first 3 months, then exercise routine under the supervision of physical therapist virtually during the last 3 months
锻炼
Self-directed and virtually supervised exercise by physical therapist for Group C
主要终点
结果指标度量标准描述时间框架
Manual Muscle Test (MMT)
Score of manual muscle strength test scale. This is a strength exam at bedside of muscle groups
From enrollment to the end of treatment at 6 months
Six-minute walking test
Distance in meters that subject can walk in six minutes
From enrollment to the end of treatment at 6 months
次要终点
结果指标度量标准描述时间框架
Quantitative myometry
Muscle dynamometry of different muscle groups measured in kilograms
From enrollment to the end of treatment at 6 months
Muscle resistance/reactance measures in ohms
using electrical impedance myography, resistance and reactance measures in ohms will be obtained simultaneously from each examined muscle
From enrollment to the end of treatment at 6 months
资格标准

适龄参与研究
成人, 老年人
最低年龄要求
18 Years
适龄性别
全部
  • Patients with genetically confirmed myotonic dystrophy 2 (DM2) who are ≥18 and ≤ 70 years old.
  • Patients are ambulatory without need of any assistance or device.
  • Patients have a normal ECG within the 3 months prior to Screening visit (of note, patients with DM2 are recommended to have routine ECG as part of patient care. So, this ECG will be done as part of patient care).
  • Body mass index (BMI) ≥20 and ≤30.

  • Subjects younger than 18 years old or older than 70 years old.
  • Inability or unwillingness of the subject to give written informed consent.
  • Subjects with pacemaker.
  • Blood pressure <90/50 mmHg or >160 mmHg/90 mmHg at Screening visit
  • Resting heart rate of <60 or >100 beats/minute at Screening visit.
  • Any fall within the last six months.
  • Any history of syncopal episodes or family history of sudden death.
  • Patients who are pregnant or plan to become pregnant. A urine pregnancy test will be performed at visit 1 and 3 for women of childbearing age. If positive or if subject is planning to become pregnant, subject will be not eligible for the study.
Massachusetts General Hospital logoMassachusetts General Hospital
研究责任方
Paloma Gonzalez Perez, MD, PhD, 主要研究者, Neurologist, Massachusetts General Hospital
研究中心联系人
联系人: Zoe Sheitman, DPT, 617-726-3642, [email protected]
1 位于 1 个国家/地区的研究中心

Massachusetts

Neuromuscular Diagnostic Center. Massachusetts General Hospital, Boston, Massachusetts, 02114, United States
Zoe Sheitman, DPT, 联系人, 6177245297, [email protected]
招募中